FoxO1 Promotes Mitophagy in the Podocytes of Diabetic Male Mice via the PINK1/Parkin Pathway
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
We recently showed that forkhead-box class O1 (FoxO1) activation protects against high glucose-induced injury by preventing mitochondrial dysfunction in the rat kidney cortex. In addition, FoxO1 has been reported to mediate putative kinase 1 (PINK1) transcription and promote autophagy in response to mitochondrial oxidative stress in murine cardiomyocytes. In this study, we ascertained whether overexpressing FoxO1 in the kidney cortex reverses preestablished diabetic nephropathy in animal models. The effect of FoxO1 on mitophagy signaling pathways was evaluated in mouse podocytes. In vivo experiments were performed in male KM mice. A mouse model of streptozotocin (STZ)-induced type 1 diabetes (T1D) was used, and lentiviral vectors were injected into the kidney cortex to overexpress FoxO1. A mouse podocyte cell line was treated with high concentrations of glucose and genetically modified using lentiviral vectors. We found aberrant mitochondrial morphology and reduced adenosine triphosphate production. These mitochondrial abnormalities were due to decreased mitophagy via reduced phosphatase/tensin homolog on chromosome 10-induced PINK1/Parkin-dependent signaling. FoxO1 upregulation and PINK1/Parkin pathway activation can individually restore injured podocytes in STZ-induced T1D mice. Our results link the antioxidative activity of FoxO1 with PINK1/Parkin-induced mitophagy, indicating a novel role of FoxO1 in diabetic nephropathy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“suggesting a role for FOXO1 in the regulation of mitophagy in podocytes134.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [134]
In the citing paper
“In addition, overexpression of FOXO1 in podocytes activated PINK1–parkin-dependent mitophagy, which eliminated aberrant mitochondria and ameliorated podocyte injury in STZ-induced diabetic mice”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [134]
Citations
Cites
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056 · cited 7×
“2016-1970 Endocrinology, July 2017, 158(7):2155–2167 https://academic.”
BackgroundInfluentialAkt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594 · cited 1×
“(8) FoxO3 has been reported to stimulate lysosomal proteolysis by activating autophagy via a transcriptional mechanism in muscle cells.”
BackgroundParkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
Autophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608 · cited 1×
“Autophagy is a highly regulated lysosomal pathway (1) that is particularly important in quiescent and terminally differentiated cells.”
BackgroundRabinowitz, J. D., & White, E. (2010) · Science · doi:10.1126/science.1193497 · Cited by 1,982
FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress
Tothova, Z., Kollipara, R., Huntly, B. J., Lee, B. H., Castrillon, D. H., Cullen, D. E., McDowell, E. P., Lazo-Kallanian, S., Williams, I. R., Sears, C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.01.003 · Cited by 1,562 · cited 1×
“(23) This result agrees with our observation in CIMPs: cells that overexpressed FoxO1 showed a mark ed reduction in ROS content under HG conditions.”
ResultZhao, J., Brault, J. J., Schild, A., Cao, P., Sandri, M., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.004 · Cited by 1,489 · cited 1×
“(8) FoxO3 has been reported to stimulate lysosomal proteolysis by activating autophagy via a transcriptional mechanism in muscle cells.(9) FoxO1 acetylation occurs in autophagy mediated by benzyl isothiocyanate and curcumin.”
BackgroundOxidative Stress as a Major Culprit in Kidney Disease in Diabetes
Forbes, J. M., Coughlan, M. T., & Cooper, M. E. (2008) · Diabetes · doi:10.2337/db08-0057 · Cited by 1,203 · cited 1×
“A growing body of evidence indicates that mitochondrial dysfunction may be pathologic in diabetic kidney disease (21, 22).”
BackgroundEssential role for Nix in autophagic maturation of erythroid cells
Sandoval, H., Thiagarajan, P., Dasgupta, S. K., Schumacher, A., Prchal, J. T., Chen, M., & Wang, J. (2008) · Nature · doi:10.1038/nature07006 · Cited by 1,185 · cited 1×
“Mitophagy has been mainly regarded as an acute degradative process that is triggered by local and severe mitochondrial damage or as part of a developmental process for removing excess mitochondria (18 – 20).”
BackgroundPINK1 and Parkin Target Miro for Phosphorylation and Degradation to Arrest Mitochondrial Motility
Wang, X., Winter, D., Ashrafi, G., Schlehe, J., Wong, Y. L., Selkoe, D., Rice, S., Steen, J., LaVoie, M. J., & Schwarz, T. L. (2011) · Cell · doi:10.1016/j.cell.2011.10.018 · Cited by 1,171 · cited 1×
“(12-14) However, whether FoxO1 is also involved in PINK1mediated autophagy in podocytes under diabetic cond iti s is not well understood.”
Background
Cited by
Mitochondrial dysfunction in diabetic kidney disease
Forbes, J. M., & Thorburn, D. R. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.9 · Cited by 634
Lin, Q., Li, S., Jiang, N., Shao, X., Zhang, M., Jin, H., Zhang, Z., Shen, J., Zhou, Y., Zhou, W., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101254 · Cited by 632
Mitochondrial quality control in kidney injury and repair
Tang, C., Cai, J., Yin, X.-M., Weinberg, J. M., Venkatachalam, M. A., & Dong, Z. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00369-0 · Cited by 513
Autophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
Mechanisms of podocyte injury and implications for diabetic nephropathy
Barutta, F., Bellini, S., & Gruden, G. (2022) · Clinical Science · doi:10.1042/cs20210625 · Cited by 221
“The SIRT1-PGC1 α -FOXO1 pathway is implicated in PINK1 down-regulation [276,277] and podocyte-specific forkhead box protein O1 (FOXO1) overexpression restores PINK1 expression and reduces both mitochondrial dysfunction and podocyte injury [278].”
Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential
Yang, D., Livingston, M. J., Liu, Z., Dong, G., Zhang, M., Chen, J.-K., & Dong, Z. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2639-1 · Cited by 252
“Overexpression of FoxO1 promoted mitophagy via PTEN-induced putative kinase 1 (PINK1)/Parkin pathway, leading to the amelioration of podocyte injury [174].”
BackgroundMitochondrial dysfunction in diabetic kidney disease
Wei, P. Z., & Szeto, C. C. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.07.005 · Cited by 208
Mitochondrial quality control mechanisms as molecular targets in diabetic heart
Chang, X., Li, Y., Cai, C., Wu, F., He, J., Zhang, Y., Zhong, J., Tan, Y., Liu, R., Zhu, H., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155313 · Cited by 185
Zhou, D., Zhou, M., Wang, Z., Fu, Y., Jia, M., Wang, X., Liu, M., Zhang, Y., Sun, Y., Lu, Y., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1754-3 · Cited by 162
Zhang, M., Sui, W., Xing, Y., Cheng, J., Cheng, C., Xue, F., Zhang, J., Wang, X., Zhang, C., Hao, P., et al. (2021) · Theranostics · doi:10.7150/thno.48561 · Cited by 153
“FoxO1 was also reported to function together with putative kinase 1 (PINK1) to mediate mitochondrial oxidative stress [38].”
BackgroundMolecular Interactions Between Reactive Oxygen Species and Autophagy in Kidney Disease
Kaushal, G. P., Chandrashekar, K., & Juncos, L. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153791 · Cited by 134
“In diabetic nephropathy, Pink1 transcriptional activity is controlled by the antioxidant FOXO 1, which promotes mitophagy and protects injured podocytes under HG conditions [193].”
BackgroundBordi, M., Darji, S., Sato, Y., Mellén, M., Berg, M. J., Kumar, A., Jiang, Y., & Nixon, R. A. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1752-5 · Cited by 124
Huang, F., Wang, Q., Guo, F., Zhao, Y., Ji, L., An, T., Song, Y., Liu, Y., He, Y., & Qin, G. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.002 · Cited by 124
Self-citationMitochondria in Diabetic Kidney Disease
Ahmad, A. A., Draves, S. O., & Rosca, M. G. (2021) · Cells · doi:10.3390/cells10112945 · Cited by 126
Autophagy Function and Regulation in Kidney Disease
Kaushal, G. P., Chandrashekar, K., Juncos, L. A., & Shah, S. V. (2020) · Biomolecules · doi:10.3390/biom10010100 · Cited by 118
Critical role of mitochondrial dysfunction and impaired mitophagy in diabetic nephropathy
Saxena, S., Mathur, A., & Kakkar, P. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28712 · Cited by 100
“Recently, it has been reported that FoxO1 activity gets compromised under high glucose conditions, overexpression of which results in restoration of high glucose mediated suppression of PINK1/Parkin dependent mitophagy in podocytes of diabetic male mice (X.‐Q. Li et al., 2017).”
BackgroundXing, L., Ji, F., Zhu, B., Wang, L., Chen, J., Wang, Y., Huang, J., Wang, H., & Yao, X. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119068 · Cited by 91
Mitochondrial dysfunction and oxidative stress: Role in chronic kidney disease
Srivastava, A., Tomar, B., Sharma, D., & Rath, S. K. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121432 · Cited by 93
Ji, L., Wang, Q., Huang, F., An, T., Guo, F., Zhao, Y., Liu, Y., He, Y., Song, Y., & Qin, G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3286928 · Cited by 90
Self-citationJiang, X.-S., Chen, X., Hua, W., He, J., Liu, T., Li, X.-J., Wan, J., Gan, H., & Du, X. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.170 · Cited by 88
FoxO transcription factors in mitochondrial homeostasis
Cheng, Z. (2022) · Biochemical Journal · doi:10.1042/bcj20210777 · Cited by 89
Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction
Liu, S., Yuan, Y., Yi, X., Xing, C., & Zhang, B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.832887 · Cited by 94
Autophagy in traumatic brain injury: a new target for therapeutic intervention
Zhang, L., & Wang, H. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00190 · Cited by 82
Podocyte Bioenergetics in the Development of Diabetic Nephropathy: The Role of Mitochondria
Audzeyenka, I., Bierżyńska, A., & Lay, A. C. (2021) · Endocrinology · doi:10.1210/endocr/bqab234 · Cited by 87
“Moreover, activation of PINK1/Parkin1 signaling in HG-exposed podocytes and in renal cortex in diabetic animal models improves cellular and glomerular injury (87).”
BackgroundZhu, W., Yuan, Y., Liao, G., Li, L., Liu, J., Chen, Y., Zhang, J., Cheng, J., & Lu, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0861-x · Cited by 80
Cell Apoptosis and Autophagy in Renal Fibrosis
Zhao, X., Livingston, M. J., Liang, X., & Dong, Z. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8871-2_28 · Cited by 78
Metabolic Changes and Oxidative Stress in Diabetic Kidney Disease
Sakashita, M., Tanaka, T., & Inagi, R. (2021) · Antioxidants · doi:10.3390/antiox10071143 · Cited by 81
“Furthermore, forkhead Box O1 (FOXO1) expression in podocytes restores PINK1 expression and alleviates STZinduced DKD [23].”
BackgroundLiu, T., Yang, L., Mao, H., Ma, F., Wang, Y., & Zhan, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.772386 · Cited by 80
Huang, F., Zhao, Y., Wang, Q., Hillebrands, J., van den Born, J., Ji, L., An, T., & Qin, G. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00441 · Cited by 74
“Diabetes was induced as described previously (23).”
MethodSelf-citationThe complicated role of mitochondria in the podocyte
Gujarati, N. A., Vasquez, J. M., Bogenhagen, D. F., & Mallipattu, S. K. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00393.2020 · Cited by 73
Wen, D., Tan, R., Zhao, C.-Y., Li, J., Zhong, X., Diao, H., Lin, X., Duan, D. D., Jun-ming, F., Xie, X., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00732 · Cited by 66
MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1
Zhang, L., Chen, Y., Jia, J., Zhu, X., He, Y., & Wu, L.-M. (2019) · Cancer Biomarkers · doi:10.3233/cbm-181229 · Cited by 62
“Several studies have reported that FOXO1 activation in various cell lines can inhibit cell survival, which can be attributed to modulation of Wnt/ β -catenin signalling [30,34,40].”
Self-citationHyperglycemia alters mitochondrial respiration efficiency and mitophagy in human podocytes
Audzeyenka, I., Rachubik, P., Typiak, M. J., Kulesza, T., Topolewska, A., Rogacka, D., Angielski, S., Saleem, M. A., & Piwkowska, A. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112758 · Cited by 67
Nestin protects podocyte from injury in lupus nephritis by mitophagy and oxidative stress
Tian, Y., Guo, H., Miao, X., Yu, J., Yang, R., Zhao, L., Liu, J., Yang, L., Gao, F., Zhang, W., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2547-4 · Cited by 63
Hormonal regulation of metabolism—recent lessons learned from insulin and estrogen
Tao, Z., & Cheng, Z. (2023) · Clinical Science · doi:10.1042/cs20210519 · Cited by 74
Jiang, T., Liu, T., Deng, X., Ding, W., Yue, Z., Yang, W., Lv, X., & Li, W. (2021) · Respiratory Research · doi:10.1186/s12931-021-01855-0 · Cited by 59
Self-citationMitochondrial Dysfunction and Diabetic Nephropathy: Nontraditional Therapeutic Opportunities
Zhang, P., Zhou, M., Guo, J., Zheng, H., Tang, J., Zhang, C., Liu, Y., Liu, W. J., & Wang, Y. (2021) · Journal of Diabetes Research · doi:10.1155/2021/1010268 · Cited by 63
PINK1 Deficiency Ameliorates Cisplatin-Induced Acute Kidney Injury in Rats
Zhou, L., Zhang, L., Zhang, Y., Yu, X., Sun, X., Zhu, T., Li, X., Liang, W., Han, Y., & Qin, C. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01225 · Cited by 57
Autophagy and mitophagy: physiological implications in kidney inflammation and diseases
Bhatia, D., & Choi, M. E. (2023) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00012.2023 · Cited by 57
Franco, F., Bevilacqua, A., Wu, R.-M., Kao, K., Lin, C., Rousseau, L., Peng, F., Chuang, Y., Peng, J.-J., Park, J., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adf7579 · Cited by 55
“Because the expression of Forkhead box protein O1 (FOXO1) plays a critical role in orchestrating the differentiation program and metabolic reprogramming needed for CD8 memory T cells (36–38) and FOXO1 has been shown to stimulate mitophagy in podocytes (37), we examined whether FOXO1 supports the expression of Park2 an…”
BackgroundThe Role of Mitochondria in Diabetic Kidney Disease and Potential Therapeutic Targets
Takasu, M., Kishi, S., Nagasu, H., Kidokoro, K., Brooks, C. R., & Kashihara, N. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.10.035 · Cited by 58
“68,84 87 Restoring mitophagy has shown potential in halting DKD progression.”
Liu, X., Cao, K., Lv, W., Feng, Z., Liu, J., Gao, J., Li, H., Zang, W., & Liu, J. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.03.011 · Cited by 48
Zheng, T., Wang, H., Chen, Y., Chen, X., Wu, Z., Hu, Q.-Y., & Sun, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.897046 · Cited by 57
“Consistent with our findings, there is also increasing evidence confirming links between decreased mitophagy in both type 1 diabetic nephropathy and type 2 diabetic nephropathy (Li et al., 2017; Xiao et al., 2017; Zhou et al., 2019).”
ResultSIRT1 rs10823108 and FOXO1 rs17446614 responsible for genetic susceptibility to diabetic nephropathy
Zhao, Y., Wei, J., Hou, X., Liu, H., Guo, F., Zhou, Y., Zhang, Y., Qu, Y., Gu, J., Zhou, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10612-7 · Cited by 47
Self-citationZhao, Y., & Sun, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117382 · Cited by 47
The role of mitochondrial-related nuclear genes in age-related common disease
Li, H., Slone, J. D., & Huang, T. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.04.012 · Cited by 46
Erythropoietin Mitigates Diabetic Nephropathy by Restoring PINK1/Parkin-Mediated Mitophagy
Yi, X., Yan, W., Guo, T., Liu, N., Wang, Z., Shang, J., Wei, X., Cui, X. Y., Sun, Y., Ren, S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.883057 · Cited by 44
“Many studies have shown that decreased level of PINK1/Parkin-mediated mitophagy is involved in the development of DN (Li et al., 2017; Jiang et al., 2020).”
The Loss of Mitochondrial Quality Control in Diabetic Kidney Disease
Dai, W., Lu, H., Chen, Y., Yang, D., Sun, L., & He, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.706832 · Cited by 40
“Forkhead-box class O1 (FoxO1) has been reported to mediate PINK1 transcription and promote mitophagy in response to mitochondrial oxidative stress (Li et al., 2017).”
BackgroundFOXO3a-dependent PARKIN negatively regulates cardiac hypertrophy by restoring mitophagy
Sun, T., Han, Y., Li, J., Jiao, X., Zuo, L., Wang, J., Yang, J., Yang, J.-L., Cao, J.-M., & Wang, J. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00935-y · Cited by 44
“A recent study has shown that FOXO1 promotes mitophagy through transcriptionally targeting PINK1 in podocytes [51].”
BackgroundAutophagy and Mitophagy in Diabetic Kidney Disease—A Literature Review
Stăniguț, A. M., Tuta, L. A., Pana, C., Alexandrescu, L., Suceveanu, A. P., Blebea, N. M., & Văcăroiu, I. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020806 · Cited by 42
“In a study on diabetic mice was described dilatation of podocytes and glomerular basement membrane thickening suggested that there is an inhibition of podocyte mitophagy influencing the progression of DN [137,138].”
Mitophagy in Diabetic Kidney Disease
Zhang, X., Feng, J., Li, X., Wu, D., Wang, Q., Li, S., & Shi, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.778011 · Cited by 40
Self-citationChen, K., Chen, J., Wang, L., Yang, J., Xiao, F., Wang, X., Yuan, J., Wang, L., & He, Y. (2020) · The FASEB Journal · doi:10.1096/fj.202000053r · Cited by 39
Guo, F., Wang, W., Song, Y., Wu, L., Wang, J., Zhao, Y., Ma, X., Ji, H., Liu, Y., Li, Z., et al. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1783481 · Cited by 40
“Importantly, FOXO1 overexpression promotes mitophagy in podocytes which were treated with high-glucose through inducing the activation of the PINK1-Parkin pathway [20], indicating the PINK1-Parkin pathway plays an important role in promoting mitophagy of podocytes under high-glucose condition.”
BackgroundSelf-citationWang, Y., & He, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.630617 · Cited by 41
“The transcriptional activity of FoxO1 decreased in the kidney from type 1 diabetic rodents induced by streptozotocin (STZ) and the podocytes cultured under high-glucose (HG) condition (Guo et al., 2015; Du et al., 2016; Li et al., 2016; Li et al., 2017).”
BackgroundMitochondrial Contribution to Inflammation in Diabetic Kidney Disease
Mitrofanova, A. V., Fontanella, A. M., Burke, G. W., Merscher, S., & Fornoni, A. (2022) · Cells · doi:10.3390/cells11223635 · Cited by 39
Identification of ULK1 as a novel mitophagy-related gene in diabetic nephropathy
Yang, Y., Gao, Z., Mao, Z., Liu, D., Liu, Z., & Wu, P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1079465 · Cited by 36
“Another study reported that forkhead-box class O1 (FoxO1) promotes mitophagy through a PINK1/Parkin pathway, thereby reducing podocyte damage in diabetic nephropathy (16).”
BackgroundLiu, B., Wang, D., Cao, Y., Wu, J., Zhou, Y., Wu, W., Wu, J., Zhou, J., & Qiu, J. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175136 · Cited by 35
Glucose- and Non-Glucose-Induced Mitochondrial Dysfunction in Diabetic Kidney Disease
Ito, M., Gurumani, M. Z., Merscher, S., & Fornoni, A. (2022) · Biomolecules · doi:10.3390/biom12030351 · Cited by 35
“Subsequently, PINK1 homodimerizes and autophosphorylates to recruit E3 ubiquitin ligase parkin and ubiquitin, directing the mitochondria to the mitophagy pathway.”
BackgroundInfluentialRegulation of mitochondrial function by forkhead transcription factors
Jerome, M. S., Kuthethur, R., Kabekkodu, S. P., & Chakrabarty, S. (2022) · Biochimie · doi:10.1016/j.biochi.2022.03.013 · Cited by 33
Shaping Up Mitochondria in Diabetic Nephropathy
Mise, K., Galvan, D. L., & Danesh, F. R. (2020) · Kidney360 · doi:10.34067/kid.0002352020 · Cited by 35
“PINK1/Parkin-mediated mitophagy levels are reported to be significantly decreased in DN in animal models and in patients with DN (68,69).”
BackgroundMelatonin Treatment Improves Renal Fibrosis via miR-4516/SIAH3/PINK1 Axis
Yoon, Y. M., Go, G., Yoon, S., Lim, J. H., Lee, G., Lee, J. H., & Lee, S. H. (2021) · Cells · doi:10.3390/cells10071682 · Cited by 33
“Similarly, a genetic study have demonstrated that overexpression of forkhead box class O1 (FOXO1) in rat kidney cortex, which enhanced PINK1/Parkin mitophagy, provided protective effect against high glucose-induced kidney injury [29].”
BackgroundThe Mitochondrion: A Promising Target for Kidney Disease
Tanrıöver, C., Çöpür, S., Uçku, D., Cakir, A. B., Hasbal, N. B., Soler, M. J., & Kanbay, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020570 · Cited by 32
“Similarly, impairment of mitophagy has been illustrated in podocytes when exposed to a high glucose environment or in the specimens from mice models of streptozotocin-induced diabetic kidney disease [76,77].”
BackgroundWang, Y., Xu, Y., Wang, Q., Guo, F., Song, Y., Fan, X., Shao, M., Chen, D., Zhang, W., & Qin, G. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176042 · Cited by 30
Self-citationZhao, W., Zhao, B., Meng, X., Li, B., Wang, Y., Yu, F., Fu, C., Yu, X., Li, X., Dai, C., et al. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13459 · Cited by 30
Shen, J. F., Li, G., Zhu, Y., Xu, Q., Zhou, H., Xu, K., Huang, K., Zhan, R., & Pan, J. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16537 · Cited by 29
HIF‐1α Ameliorates Diabetic Neuropathic Pain via Parkin‐Mediated Mitophagy in a Mouse Model
He, J., Qin, Z., Chen, X., He, W., Li, D., Zhang, L., Le, Y., Xiong, Q., Zhang, B., & Wang, H. (2022) · BioMed Research International · doi:10.1155/2022/5274375 · Cited by 29
“Furthermore, Parkin was involved in hyperglycemia-induced heart [34] and kidney dysfunction [35].”
InfluentialCai, J., Guan, H., Li, D., Shi, B., Jiang, Y., Qiao, S., Liu, Q., Fang, C., & Zhang, Z. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.109046 · Cited by 29
Tang, S., Hao, D., Ma, W., Liu, L., Gao, J., Yao, P., Yu, H., Gan, L., & Cao, Y. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0213 · Cited by 32
“This occurs in a sirtuin 1 (Sirt1)-dependent manner, which has been proven by gain-and loss-of-function experiments [20,70].”
BackgroundSIRT1 Regulates Fumonisin B1-Induced LMH Cell PANoptosis and Antagonism of Lycopene
Wang, X., Chang, Y., Wang, X., Liu, R., Yang, S.-J., Hu, Z.-Y., Jiang, F., Chen, M., Wang, J.-X., Liu, S., et al. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c11658 · Cited by 28
Zhu, S., Li, X., Zhao, Y. P., Dai, X., Guo, J., & Li, J. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c05103 · Cited by 28
Zhang, L., Miao, M., Xu, X., Bai, M., Wu, M., & Zhang, A. (2023) · Kidney Diseases · doi:10.1159/000530485 · Cited by 30
Hughes, E. P., Wang, X. X., Sabol, L., Barton, K., Hegde, S., Myakala, K., Krawczyk, E., Rosenberg, A. Z., & Levi, M. (2025) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00110.2025 · Cited by 29
Organelle dynamics of endothelial mitochondria in diabetic angiopathy
Xiang, H., Song, R., Ouyang, J., Zhu, R., Shu, Z., Liu, Y., Wang, X., Zhang, D., Zhao, J., & Lu, H. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173865 · Cited by 30
Important regulatory role of mitophagy in diabetic microvascular complications
Hu, X., Lv, J., Zhao, Y., Li, X., Qi, W., & Wang, X. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06307-7 · Cited by 25
“Using HG-induced mouse podocytes (CIMPs) and STZ-induced KM mouse models with lentiviral treatment overexpressing forkhead box protein O1 (FoxO1), FoxO1 was found to promote mitophagy in diabetic mouse podocytes through the PINK1/Parkin pathway [115].”
KCa3.1 Mediates Dysregulation of Mitochondrial Quality Control in Diabetic Kidney Disease
Huang, C., Yi, H., Shi, Y., Cao, Q., Shi, Y., Cheng, D., Braet, F., Chen, X., & Pollock, C. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.573814 · Cited by 26
“, 2013), and diabetic kidney disease (Li et al., 2017; Xiao et al., 2017).”
BackgroundZhu, S., Li, C., Tong, Y.-X., Xu, Y., Wang, Z., & Li, J. (2022) · Food & Function · doi:10.1039/d2fo01497a · Cited by 24
Yoon, Y. M., Han, Y., Yun, C. W., Lee, J. H., Kim, R., & Lee, S. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102898 · Cited by 28
“Decreasing PINK-1 leads to an accumulation of dysfunctional mitochondria, due to reduced mitophagy in combination with increase in mitochondrial fusion (mitofusion) [34,35].”
BackgroundMechanisms and implications of podocyte autophagy in chronic kidney disease
Njeim, R., Merscher, S., & Fornoni, A. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00415.2023 · Cited by 23
Pabón, M. A., Patiño, E., Bhatia, D., Rojas, J., Ma, K. C., Finkelsztein, E. J., Osorio, J. C., Malick, F., Polverino, F., Owen, C. A., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99592 · Cited by 23
“may have important roles in the pathogenesis of kidney diseases (74, 75).”
BackgroundSherkhane, B., Kalvala, A. K., Arruri, V. K., Khatri, D. K., & Singh, S. B. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23032 · Cited by 24
Mitochondrial quality control and its emerging role in the pathogenesis of diabetic kidney disease
Baek, J., Lee, Y. H., Jeong, H. Y., & Lee, S. (2023) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.22.233 · Cited by 23
“Mitophagy is an important defense mechanism during cellular stress, and inappropriate mitophagy can exacerbate podocyte injury [64,65].”
BackgroundLiu, P., Guo, C., Cui, Y., Zhang, X., Xiao, B., Liu, M., Song, M., & Li, Y. (2022) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2022.111765 · Cited by 19
Yoon, Y. M., Kim, S., Han, Y., Yun, C. W., Lee, J. H., Noh, H., & Lee, S. H. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101144 · Cited by 19
“Recent studies revealed that downregulation of PINK1 disrupts the regulation of mitochondrial mitophagy in CKD, and mitochondria in the CKD model undergo impairment of mitochondrial fission thereby enlarged, dysfunctional mitochondria are formed [37,38].”
BackgroundJi, L., Wang, Q., Liu, M., Zhu, C., Xiao, Y., Han, J., Fang, Y., Ye, J., Yin, J., & Wei, L. (2021) · FEBS Letters · doi:10.1002/1873-3468.14063 · Cited by 18
Self-citationWang, X., Lang, R., Zeng, Q., Liang, Y. J., Chen, N., Ma, Z., & Yu, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-97137-2 · Cited by 19
Systems biology and machine learning approaches identify drug targets in diabetic nephropathy
Abedi, M., Marateb, H. R., Mohebian, M. R., Aghaee‐Bakhtiari, S. H., Nassiri, S. M., & Gheisari, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-02282-3 · Cited by 20
“Interestingly, the critical role of the majority of the central nodes such as Hif1a, Vegfa, Sirt1, and Foxo1 has been shown in previous studies 78–81 .”
BackgroundRegulation of Mitochondrial Homeostasis and Nrf2 in Kidney Disease: Timing Is Critical
Zhuang, Y., Hu, L., Wu, Y. F., Yang, C., Li, S., Jing, K., & Liu, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9275056 · Cited by 17
“Thereafter, using streptozotocin-induced diabetic mice and a mouse podocyte line cultured in high-glucose medium, Li et al. [59] showed that forkhead-box class O1 (FoxO1) promotes podocyte injury repair and delays the progression of diabetic nephropathy by inducing PINK1/Parkin-mediated mitophagy.”
Liu, T., Jin, Q., Yang, L., Mao, H., Ma, F., Wang, Y., Li, P., & Zhan, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1142276 · Cited by 21
The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease
Huang, C., Bian, J., Cao, Q., Chen, X., & Pollock, C. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041525 · Cited by 20
Mitochondria Dictate Function and Fate of HSCs and T Cells
Xu, Y., Chiang, Y.-H., Ho, P., & Vannini, N. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0685 · Cited by 16
PTEN-induced kinase 1 deficiency alters albumin permeability and insulin signaling in podocytes
Audzeyenka, I., Rachubik, P., Typiak, M. J., Kulesza, T., Kalkowska, D., Rogacka, D., Rychłowski, M., Angielski, S., Saleem, M. A., & Piwkowska, A. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02204-4 · Cited by 16
“The activation of PINK1/Parkin1 signaling in HG-exposed podocytes and in the renal cortex in diabetic animal models improved cellular and glomerular injury by restoring nephrin, desmin, and podocalyxin levels and by lowering accumulation of the mesangial matrix [23].”
BackgroundJiang, H., Jiang, Y., Xu, Y., Yuan, D., & Li, Y. (2022) · Experimental Lung Research · doi:10.1080/01902148.2022.2037169 · Cited by 17
Meng, Q., Chen, Z., Gao, Q., Hu, L., Li, Q., Li, S., Cui, L., Feng, Z., Zhang, X., Cui, S., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5583512 · Cited by 15
“Still, a speci fi c binding site has not been investigated, and the primers used for CHIP resulted in a product exceeding 1600 bp [52].”
Sung, M. J., An, H., Ha, M. H., Park, S. H., Jeong, H. Y., Baek, J., Lee, S. H., Lee, Y. H., & Lee, S.-Y. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.83906 · Cited by 17
“[8,31,32,35,38].”
BackgroundResultInfluentialPolycystin‐1 regulates cardiomyocyte mitophagy
Ramírez‐Sagredo, A., Quiroga, C., Garrido‐Moreno, V., López‐Crisosto, C., Leiva‐Navarrete, S., Norambuena‐Soto, I., Ortiz‐Quintero, J., Díaz‐Vesga, M. C., Perez, W., Hendrickson, T., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002598r · Cited by 16
Up‐regulation of FoxO1 contributes to adverse vascular remodelling in type 1 diabetic rats
Liu, J., Xie, X., Yan, D., Wang, Y., Yuan, H., Cai, Y., Luo, J., Xu, A., Huang, Y., Cheung, C. W., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15935 · Cited by 14
Mitochondrial dysfunction: the hidden catalyst in chronic kidney disease progression
Chen, J., Zhou, Q., Su, L., & Ni, L. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2506812 · Cited by 20
“…atrophy protein 1; nF-κB: nuclear factor-kappa B; SSR: severe steroid-resistant asthma; TePP-46: a PKM2 agonis. inhibiting mitochondrial autophagy [42,214]. overexpression of foXo1 in podocytes activates PiNK1/Parkin-dependent mitophagy, degrades dysfunctional mitochondria, and alleviates…”
miR-378a-3p Participates in Metformin’s Mechanism of Action on C2C12 Cells under Hyperglycemia
Machado, I. F., Teodoro, J. S., Castela, A. C., Palmeira, C. M., & Rolo, A. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020541 · Cited by 12
“Mitophagy has been previously shown to be impaired during hyperglycemia [51], mitophagy-related proteins were reported to be decreased in T2DM human patients [52] and mitophagy-related genes were shown to be downregulated in the skeletal muscle of T2DM patients [53].”
BackgroundUrinary podocyte markers in diabetic kidney disease
Li, C., & Szeto, C. (2024) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.23.109 · Cited by 12
“Additionally, the lack of proper mitochondrial turnover in the diabetic kidney is due to the inhibition of mitophagy [14,15].”
BackgroundQin, X., Chen, H., Zhu, X., Xu, X.-J., & Gao, J. (2023) · Pharmaceutical Biology · doi:10.1080/13880209.2023.2233998 · Cited by 11
“Li et al. (2017) reported that Pink1/Parkin pathway activation alone improves impaired podocytes in diabetic nephropathy.”
Background
Metadata
- Authors
- Li, W., Du, M., Wang, Q., Ma, X., Wu, L., Guo, F., Ji, H., Huang, F., & Qin, G.
- Affiliations
- First Affiliated Hospital of Zhengzhou University (CN)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2017-05-12
- Volume
- 158
- Issue
- 7
- Pages
- 2155-2167
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2613819022
- Cited by
- 146
- References
- 28
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 12 · 2023: 19 · 2022: 23 · 2021: 25 · 2020: 17 · 2019: 15 · 2018: 7 · 2017: 2
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- Zhengzhou University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- FOXO1, mitophagy, podocytes, diabetic nephropathy, PINK1/Parkin pathway, type 1 diabetes, mitochondrial dysfunction, mitochondrial morphology, ATP production, high glucose, streptozotocin-induced diabetes, renal cortex, lentiviral overexpression
- MeSH terms
- Forkhead Box Protein O1, PTEN-Induced Putative Kinase, Animals, Cells, Cultured, Diabetes Mellitus, Experimental, Diabetic Nephropathies, Male, Mitochondria, Protein Kinases, Signal Transduction, Reactive Oxygen Species, Ubiquitin-Protein Ligases, Podocytes, Mice, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.